SELLAS Life Sciences Group, Inc. - Common Stock (SLS)
CUSIP: 81642T209
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 178,475,456
- Total 13F shares
- 4,056,846
- Share change
- -3,660,261
- Total reported value
- $4,828,846
- Put/Call ratio
- 1.7%
- Price per share
- $1.19
- Number of holders
- 29
- Value change
- -$3,466,325
- Number of buys
- 21
- Number of sells
- 10
Quarterly Holders Quick Answers
What is CUSIP 81642T209?
CUSIP 81642T209 identifies SLS - SELLAS Life Sciences Group, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 81642T209:
Top shareholders of SLS - SELLAS Life Sciences Group, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Anson Funds Management LP |
13F
|
Company |
2.7%
|
4,832,368
|
$4,880,692 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.85%
|
1,513,235
|
$1,528,367 | — | 31 Mar 2024 | |
| Barbara A. Wood |
3/4/5
|
EVP, Gen. Counsel, Corp. Sec. |
—
mixed-class rows
|
249,450
mixed-class rows
|
$821,565 | — | 22 Jan 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.16%
|
278,218
|
$281,000 | — | 31 Mar 2024 | |
| Robert Francomano |
3/4/5
|
Chief Commercial Officer |
—
mixed-class rows
|
91,836
mixed-class rows
|
$278,365 | — | 22 Jan 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.15%
|
273,063
|
$275,867 | — | 31 Mar 2024 | |
| Opus Capital Group, LLC |
13F
|
Company |
0.11%
|
200,600
|
$203,000 | — | 31 Mar 2024 | |
| Equitable Holdings, Inc. |
13F
|
Company |
0.11%
|
200,000
|
$202,000 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.05%
|
97,129
|
$98,100 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.05%
|
88,730
|
$89,618 | — | 31 Mar 2024 | |
| Virtu Financial LLC |
13F
|
Company |
0.02%
|
39,429
|
$40,000 | — | 31 Mar 2024 | |
| Prosperity Financial Group, Inc. |
13F
|
Company |
0.01%
|
25,385
|
$25,639 | — | 31 Mar 2024 | |
| Mariner, LLC |
13F
|
Company |
0.01%
|
25,257
|
$25,510 | — | 31 Mar 2024 | |
| CANTOR FITZGERALD, L. P. |
13F
|
Individual |
0.01%
|
24,750
|
$24,998 | — | 31 Mar 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
20,725
|
$20,932 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.01%
|
19,718
|
$19,915 | — | 31 Mar 2024 | |
| XTX Topco Ltd |
13F
|
Company |
0.01%
|
17,391
|
$17,565 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.01%
|
16,238
|
$16,400 | — | 31 Mar 2024 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
0.01%
|
14,054
|
$14,000 | — | 31 Mar 2024 | |
| Brooklyn FI, LLC |
13F
|
Company |
0.01%
|
11,178
|
$11,290 | — | 31 Mar 2024 | |
| Nemes Rush Group LLC |
13F
|
Company |
0.01%
|
10,000
|
$10,100 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
6,092
|
$6,153 | — | 31 Mar 2024 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
1,660
|
$1,676 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
1,420
|
$1,434 | — | 31 Mar 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
301
|
$304 | — | 31 Mar 2024 | |
| Allworth Financial LP |
13F
|
Company |
0%
|
150
|
$152 | — | 31 Mar 2024 | |
| JANICZEK WEALTH MANAGEMENT, LLC |
13F
|
Company |
0%
|
11
|
$12 | — | 31 Mar 2024 | |
| Parkside Financial Bank & Trust |
13F
|
Company |
0%
|
2
|
$3 | — | 31 Mar 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0%
|
2
|
$2 | — | 31 Mar 2024 | |
| FMR LLC |
13F
|
Company |
0%
|
1
|
$1 | — | 31 Mar 2024 |
Institutional Holders of SELLAS Life Sciences Group, Inc. - Common Stock (SLS) as of Q2 2024
As of 30 Jun 2024,
SELLAS Life Sciences Group, Inc. - Common Stock (SLS) was held by
29 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,056,846 shares.
The largest 10 holders included
VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., Opus Capital Group, LLC, Equitable Holdings, Inc., Diametric Capital, LP, MILLENNIUM MANAGEMENT LLC, STATE STREET CORP, NORTHERN TRUST CORP, and Virtu Financial LLC.
This page lists
29
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
27
Q2 2024 holders
29
Holder diff
2
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.